UNSPSC 51283931: Sulfaisodimidine or sulfamethin or sulfisomidine or sulphasomidine

This classification denotes an anti-infective agent and sulfanilamide with the molecular formula C12H14N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W03L3ODK6E, chemically known as 4,6-dimethylsulfadiazine but generally known as sulfisomidine, which bears US NIH Compound Identifier 5327. European Medicines Agency schedules Sulfisomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10739MIG.

SULFISOMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.

UNSPSC 51283931 Sulfaisodimidine or sulfamethin or sulfisomidine or sulphasomidine is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The two opportunities posted under this code in the recent record are a completed pharmaceutical warehouse contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride awarded by the Illinois Department of Public Health to Chartwell Rx LLC, and a Seminole County, Florida solicitation for Naloxone and drug deactivation systems — neither of which are sulfaisodimidine or related sulfonamides. The code shows little relevant recent activity under its stated scope.

The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium on August 28, 2026, for $2,999,999.11 over 12 months with two renewal options, covering antibiotic tablet supply through an Invitation for Bid process. Seminole County, Florida posted an IFB on June 30, 2026, due July 26, 2023, seeking 1,900 units of Naloxone and 800 drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, Florida. State and local procurement under this code appears sparse and inconsistently tagged; business development professionals should verify code classification with issuing bodies before pursuing opportunities listed under 51283931.